| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2003;108:1534.)
© 2003 American Heart Association, Inc.
Focused Perspective |
From the Outcomes Research and Assessment Group, Duke Clinical Research Institute, Durham, NC (D.B.M.), and the Department of Cardiology, Cleveland Clinic Foundation, Cleveland, Ohio (M.S.L.)
Correspondence to Daniel B. Mark, MD, MPH, Professor of Medicine, Duke Clinical Research Institute, PO Box 17969, Durham, NC 27715. E-mail daniel.mark@duke.edu
Key Words: Editorials exercise coronary disease prognosis
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
Clinicians have long been aware that patients capable of high levels of physical exertion have a better prognosis than those with limited exercise capacity. Although the initial clinical encounter usually suffices to gain a qualitative appreciation of functional capacity, more precision can be obtained from formal graded exercise testing. In both asymptomatic subjects and patients with clinical coronary artery disease (CAD), exercise-based measures of functional capacity repeatedly have been shown to provide powerful independent prognostic information.1,2 Yet when decisions are made about the role and value of exercise testing in clinical cardiology, the focus is inevitably on measures believed to reflect the state of the coronary arterial circulation and the potential need for angiography and revascularization. The widespread tendency to ignore exercise capacity in clinical management seems to be a function of a general uncertainty about its therapeutic implications. Stress-induced ischemia may be less important prognostically, but its message seems clear: Fix the plumbing.
See p 1554
In symptomatic CAD patients, exercise capacity typically is used to provide the context in which ischemic responses are interpreted.3 Thus, ischemia in the setting of poor exercise capacity means high risk, whereas in the setting of good exercise capacity, ischemia (even when measured with nuclear perfusion techniques) has little prognostic impact.4 In asymptomatic subjects, in whom evidence of ischemia is quite infrequent, the utility of exercise capacity has been more of a puzzle. In the American College of Cardiology/American Heart Association Exercise Testing Guidelines,5 exercise testing for routine screening of asymptomatic men and
Related Article:
Circulation 2003 108: 1554-1559.
This article has been cited by other articles:
![]() |
A. Kumar and C. P. Cannon Acute Coronary Syndromes: Diagnosis and Management, Part II Mayo Clin. Proc., November 1, 2009; 84(11): 1021 - 1036. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Myers Exercise Capacity and Prognosis in Chronic Heart Failure Circulation, June 30, 2009; 119(25): 3165 - 3167. [Full Text] [PDF] |
||||
![]() |
P. N. Peterson, D. J. Magid, C. Ross, P. M. Ho, J. S. Rumsfeld, M. S. Lauer, E. E. Lyons, S. S. Smith, and F. A. Masoudi Association of Exercise Capacity on Treadmill With Future Cardiac Events in Patients Referred for Exercise Testing Arch Intern Med, January 28, 2008; 168(2): 174 - 179. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Spielmann, A. S. Leon, D. C. Rao, T. Rice, J. S. Skinner, T. Rankinen, and C. Bouchard Genome-wide linkage scan for submaximal exercise heart rate in the HERITAGE family study Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3366 - H3371. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Greenstone Clinician's Corner: Type 2 Diabetes: A Disease of Epidemic Proportion That Is Largely Preventable But How? American Journal of Lifestyle Medicine, October 1, 2007; 1(5): 335 - 338. [Abstract] [PDF] |
||||
![]() |
N. Spielmann, A. S. Leon, D. C. Rao, T. Rice, J. S. Skinner, C. Bouchard, and T. Rankinen CETP genotypes and HDL-cholesterol phenotypes in the HERITAGE Family Study Physiol Genomics, September 11, 2007; 31(1): 25 - 31. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Slentz, J. A. Houmard, J. L. Johnson, L. A. Bateman, C. J. Tanner, J. S. McCartney, B. D. Duscha, and W. E. Kraus Inactivity, exercise training and detraining, and plasma lipoproteins. STRRIDE: a randomized, controlled study of exercise intensity and amount J Appl Physiol, August 1, 2007; 103(2): 432 - 442. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Ignarro, M. L. Balestrieri, and C. Napoli Nutrition, physical activity, and cardiovascular disease: An update Cardiovasc Res, January 15, 2007; 73(2): 326 - 340. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mora, R. F. Redberg, A. R. Sharrett, and R. S. Blumenthal Enhanced Risk Assessment in Asymptomatic Individuals With Exercise Testing and Framingham Risk Scores Circulation, September 13, 2005; 112(11): 1566 - 1572. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. E. Kraus and P. S. Douglas Where Does Fitness Fit In? N. Engl. J. Med., August 4, 2005; 353(5): 517 - 519. [Full Text] [PDF] |
||||
![]() |
A. S. Leon, B. A. Franklin, F. Costa, G. J. Balady, K. A. Berra, K. J. Stewart, P. D. Thompson, M. A. Williams, and M. S. Lauer Cardiac Rehabilitation and Secondary Prevention of Coronary Heart Disease: An American Heart Association Scientific Statement From the Council on Clinical Cardiology (Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity), in Collaboration With the American Association of Cardiovascular and Pulmonary Rehabilitation Circulation, January 25, 2005; 111(3): 369 - 376. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. T. Levy, A. J. Hartz, P. A. James, M. Gulati, D. K. Pandey, M. F. Arnsdorf, D. S. Lauderdale, R. A. Thisted, R. H. Wicklund, and H. R. Black Exercise Capacity and the Risk of Death in Women * Response Circulation, May 25, 2004; 109(20): e224 - e224. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |